BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16209554)

  • 1. Medium term planning of biopharmaceutical manufacture using mathematical programming.
    Lakhdar K; Zhou Y; Savery J; Titchener-Hooker NJ; Papageorgiou LG
    Biotechnol Prog; 2005; 21(5):1478-89. PubMed ID: 16209554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medium term planning of biopharmaceutical manufacture with uncertain fermentation titers.
    Lakhdar K; Farid SS; Titchener-Hooker NJ; Papageorgiou LG
    Biotechnol Prog; 2006; 22(6):1630-6. PubMed ID: 17137311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiobjective long-term planning of biopharmaceutical manufacturing facilities.
    Lakhdar K; Savery J; Papageorgiou LG; Farid SS
    Biotechnol Prog; 2007; 23(6):1383-93. PubMed ID: 17924645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A software tool to assist business-process decision-making in the biopharmaceutical industry.
    Mustafa MA; Washbrook J; Lim AC; Zhou Y; Titchener-Hooker NJ; Morton P; Berezenko S; Farid SS
    Biotechnol Prog; 2004; 20(4):1096-102. PubMed ID: 15296435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Building biomanufacturing capacity--the chapter and verse.
    Kamarck ME
    Nat Biotechnol; 2006 May; 24(5):503-5. PubMed ID: 16680126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The state of biopharmaceutical manufacturing.
    Molowa DT; Mazanet R
    Biotechnol Annu Rev; 2003; 9():285-302. PubMed ID: 14650933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capacity planning for batch and perfusion bioprocesses across multiple biopharmaceutical facilities.
    Siganporia CC; Ghosh S; Daszkowski T; Papageorgiou LG; Farid SS
    Biotechnol Prog; 2014; 30(3):594-606. PubMed ID: 24376262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A decision-support model for evaluating changes in biopharmaceutical manufacturing processes.
    Chhatre S; Francis R; O'Donovan K; Titchener-Hooker NJ; Newcombe AR; Keshavarz-Moore E
    Bioprocess Biosyst Eng; 2007 Jan; 30(1):1-11. PubMed ID: 17093973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Throughput Optimization of Continuous Biopharmaceutical Manufacturing Facilities.
    Garcia FA; Vandiver MW
    PDA J Pharm Sci Technol; 2017; 71(3):189-205. PubMed ID: 27974629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel approach for inventory problem in the pharmaceutical supply chain.
    Candan G; Yazgan HR
    Daru; 2016 Feb; 24():4. PubMed ID: 26912354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How many patents does a biopharmaceutical company need?
    Parida DK; Mehdiratta R; Saberwal G
    Nat Biotechnol; 2008 Jul; 26(7):763-6. PubMed ID: 18612295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capacity management: get the level of detail right.
    Silva D
    Hosp Mater Manage Q; 1994 May; 15(4):67-74. PubMed ID: 10134157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of a decision-support tool to assess pooling strategies in perfusion culture processes under uncertainty.
    Lim AC; Zhou Y; Washbrook J; Sinclair A; Fish B; Francis R; Titchener-Hooker NJ; Farid SS
    Biotechnol Prog; 2005; 21(4):1231-42. PubMed ID: 16080707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flexible interval mixed-integer bi-infinite programming for environmental systems management under uncertainty.
    He L; Huang GH; Lu HW
    J Environ Manage; 2009 Apr; 90(5):1802-13. PubMed ID: 19111962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case study and application of process analytical technology (PAT) towards bioprocessing: use of on-line high-performance liquid chromatography (HPLC) for making real-time pooling decisions for process chromatography.
    Rathore AS; Yu M; Yeboah S; Sharma A
    Biotechnol Bioeng; 2008 Jun; 100(2):306-16. PubMed ID: 18078292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal decision rule with class-selective rejection and performance constraints.
    Grall-Maƫs E; Beauseroy P
    IEEE Trans Pattern Anal Mach Intell; 2009 Nov; 31(11):2073-82. PubMed ID: 19762932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decentralized Bayesian search using approximate dynamic programming methods.
    Zhao Y; Patek SD; Beling PA
    IEEE Trans Syst Man Cybern B Cybern; 2008 Aug; 38(4):970-5. PubMed ID: 18632386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two mathematical programming models of cheese manufacture.
    Burke JA
    J Dairy Sci; 2006 Feb; 89(2):799-809. PubMed ID: 16428648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inexact fuzzy-stochastic mixed-integer programming approach for long-term planning of waste management--Part A: methodology.
    Guo P; Huang GH
    J Environ Manage; 2009; 91(2):461-70. PubMed ID: 19800164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A tool for modeling strategic decisions in cell culture manufacturing.
    Farid SS; Novais JL; Karri S; Washbrook J; Titchener-Hooker NJ
    Biotechnol Prog; 2000; 16(5):829-36. PubMed ID: 11027178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.